Literature DB >> 8794897

Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.

J D Alvaro1, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler, R S Duman.   

Abstract

Melanocortin peptides are reported to antagonize opiate dependence and tolerance, but the neural substrates underlying these actions are unknown. In this study, we characterize the rat melanocortin-4 receptor (MC4-R) and demonstrate that this receptor is regulated by opiate administration. The rat MC4-R is 95% identical to the human MC4-R, and the potency of melanocortin peptides to stimulate cAMP production is similar in these two species homologs (alpha-melanocyte-stimulating hormone = adrenocorticotropic hormone > gamma-melanocyte-stimulating hormone). Expression of MC4-R mRNA was found to be enriched in the striatum, nucleus accumbens, and periaque-ductal gray, all of which are regions implicated in the behavioral effects of opiates. In contrast, MC1-, MC3-, and MC5-R are expressed at very low or undetectable levels in these brain regions. Chronic administration of morphine (5 days) resulted in a time-dependent down-regulation of MC4-R mRNA expression in the striatum and periaqueductal gray. Expression of MC4-R mRNA was also decreased in the nucleus accumbens/ olfactory tubercle, but this effect was observed after 1 or 3 days of morphine treatment. In the striatum, the reduction of MC4-R mRNA was accompanied by a concomitant decrease in melanocortin receptor levels, shown by quantitative radioligand binding and autoradiography. In contrast, morphine administration did not influence levels of MC4-R mRNA in several other brain regions, including frontal cortex, olfactory bulb, hypothalamus, and ventral tegmentum/substantia nigra. In light of previous findings that melanocortins antagonize opiate self-administration, analgesic tolerance, and physical dependence, we hypothesize that decreased melanocortin function, via down-regulation of MC4-R expression, may contribute to the development of these opiate-induced behaviors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794897

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

1.  Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.

Authors:  Zhi-Gang He; Bao-Wen Liu; Hong-Bing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-13

Review 2.  Novel functions of orexigenic hypothalamic peptides: from genes to behavior.

Authors:  Stephen C Benoit; Andrea L Tracy; Jon F Davis; Derrick Choi; Deborah J Clegg
Journal:  Nutrition       Date:  2008-09       Impact factor: 4.008

3.  Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice.

Authors:  M Navarro; I Cubero; L Ko; T E Thiele
Journal:  Genes Brain Behav       Date:  2009-06       Impact factor: 3.449

4.  Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain.

Authors:  S J Gold; Y G Ni; H G Dohlman; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

5.  Lateral hypothalamic melanocortin receptor signaling modulates binge-like ethanol drinking in C57BL/6J mice.

Authors:  Gretchen M Sprow; Jennifer A Rinker; Emily G Lowery-Gointa; Angela M Sparrow; Montserrat Navarro; Todd E Thiele
Journal:  Addict Biol       Date:  2015-05-15       Impact factor: 4.280

6.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

Review 7.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

8.  Decreased immunoreactivity of the polypeptide precursor pro-opiomelanocortin (POMC) and the prohormone convertase pc1/3 after chronic ethanol exposure in Sprague-Dawley rats.

Authors:  Montserrat Navarro; Inmaculada Cubero; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

9.  Melanocortin-4 receptor gene variant I103 is negatively associated with obesity.

Authors:  Frank Geller; Kathrin Reichwald; Astrid Dempfle; Thomas Illig; Caren Vollmert; Stephan Herpertz; Winfried Siffert; Matthias Platzer; Claudia Hess; Thomas Gudermann; Heike Biebermann; H-Erich Wichmann; Helmut Schäfer; Anke Hinney; Johannes Hebebrand
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

10.  Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats.

Authors:  Montserrat Navarro; Inmaculada Cubero; Darin J Knapp; George R Breese; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.